You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
The firm's full fiscal year revenues were also up, 32 percent as reported, or about 6 percent on a currency-neutral basis.
Quest Diagnostics this week announced it is acquiring the outreach laboratory services of Marin General Hospital located in Greenbrae, California.
The investment bank expects Abbott's Diagnostic division to grow in the mid-single digits driven in part by global launches of its Alinity systems.
The PCR assay is intended to help detect TB-causing bacteria and determine if it harbors mutations associated with isoniazid and rifampicin resistance.
Becton Dickinson got clearance for a platform and test for the rapid identification and determination of antimicrobial susceptibility of gram-negative bacteria.
The firm said that its system is expected to deliver up to 50 AST tests per day and match the daily production of the highest-throughput systems in the market.
Smaller multiplex molecular panels of five or fewer targets will be covered, while a determination of gastrointestinal panel coverage is expected soon.
The senior unsecured term loan facility was used, in part, to refinance a three-year loan agreement between BD, Citibank, and other lenders reached last year.
The BD business, which has annual revenues of about $100 million, offers technical services as well as peptones for cell culture media used in biopharmaceutical applications.
In response to public comment on draft recommendations published last year, the USPSTF changed course and retained cotesting as an option.